US decline hits Sun in fourth quarter
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has reported a 10% decline in sales to Rs11.34 billion ($240.6 million) for the fourth quarter ended March 31st, hit by a decline in its US business. Net profits fell by 45% to Rs3.94 billion.